{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:03:34Z","timestamp":1784394214506,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Practical Research Project for Rare\/Intractable Diseases from the Japan Agency for Medical Research and Development","award":["JP19bm0804009"],"award-info":[{"award-number":["JP19bm0804009"]}]},{"name":"JSPS KAKENHI","award":["JP13390324"],"award-info":[{"award-number":["JP13390324"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Individuals with Down syndrome (DS) commonly show unique pathological phenotypes throughout their life span. Besides the specific effects of dosage-sensitive genes on chromosome 21, recent studies have demonstrated that the gain of a chromosome exerts an adverse impact on cell physiology, regardless of the karyotype. Although dysregulated transcription and perturbed protein homeostasis are observed in common in human fibroblasts with trisomy 21, 18, and 13, whether and how this aneuploidy-associated stress acts on other cell lineages and affects the pathophysiology are unknown. Here, we investigated cellular stress responses in human trisomy 21 and 13 neurons differentiated from patient-derived induced pluripotent stem cells. Neurons of both trisomies showed increased vulnerability to apoptotic cell death, accompanied by dysregulated protein homeostasis and upregulation of the endoplasmic reticulum stress pathway. In addition, misfolded protein aggregates, comprising various types of neurodegenerative disease-related proteins, were abnormally accumulated in trisomic neurons. Intriguingly, treatment with sodium 4-phenylbutyrate, a chemical chaperone, successfully decreased the formation of protein aggregates and prevented the progression of cell apoptosis in trisomic neurons. These results suggest that aneuploidy-associated stress might be a therapeutic target for the neurodegenerative phenotypes in DS.<\/jats:p>","DOI":"10.1038\/s41598-020-70362-x","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T10:07:20Z","timestamp":1597918040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["4-Phenylbutyrate ameliorates apoptotic neural cell death in Down syndrome by reducing protein aggregates"],"prefix":"10.1038","volume":"10","author":[{"given":"Katsuya","family":"Hirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Nambara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kawatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutoshi","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Ohtaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahito","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Arahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuji","family":"Kitabatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"70362_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/GIM.0b013e3181b2e34c","volume":"11","author":"A Megarbane","year":"2009","unstructured":"Megarbane, A. et al. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet. Med. 11, 611\u2013616. https:\/\/doi.org\/10.1097\/GIM.0b013e3181b2e34c (2009).","journal-title":"Genet. Med."},{"key":"70362_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neubiorev.2019.01.001","volume":"98","author":"RA Vacca","year":"2019","unstructured":"Vacca, R. A. et al. Down syndrome: Neurobiological alterations and therapeutic targets. Neurosci. Biobehav. Rev. 98, 234\u2013255. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.01.001 (2019).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"70362_CR3","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1101\/gr.1951304","volume":"14","author":"P Kahlem","year":"2004","unstructured":"Kahlem, P. et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res. 14, 1258\u20131267. https:\/\/doi.org\/10.1101\/gr.1951304 (2004).","journal-title":"Genome Res."},{"key":"70362_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.celrep.2016.04.031","volume":"15","author":"K Banno","year":"2016","unstructured":"Banno, K. et al. Systematic cellular disease models reveal synergistic interaction of trisomy 21 and GATA1 mutations in hematopoietic abnormalities. Cell Rep. 15, 1228\u20131241. https:\/\/doi.org\/10.1016\/j.celrep.2016.04.031 (2016).","journal-title":"Cell Rep."},{"key":"70362_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","volume":"35","author":"TF Haydar","year":"2012","unstructured":"Haydar, T. F. & Reeves, R. H. Trisomy 21 and early brain development. Trends Neurosci. 35, 81\u201391. https:\/\/doi.org\/10.1016\/j.tins.2011.11.001 (2012).","journal-title":"Trends Neurosci."},{"key":"70362_CR6","doi-asserted-by":"publisher","first-page":"9962","DOI":"10.1073\/pnas.1216575110","volume":"110","author":"JP Weick","year":"2013","unstructured":"Weick, J. P. et al. Deficits in human trisomy 21 iPSCs and neurons. Proc. Natl. Acad. Sci. 110, 9962\u20139967. https:\/\/doi.org\/10.1073\/pnas.1216575110 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"70362_CR7","doi-asserted-by":"publisher","first-page":"e22126","DOI":"10.1371\/journal.pone.0022126","volume":"6","author":"J Lu","year":"2011","unstructured":"Lu, J. et al. S100B and APP promote a gliocentric shift and impaired neurogenesis in Down syndrome neural progenitors. PLoS ONE 6, e22126. https:\/\/doi.org\/10.1371\/journal.pone.0022126 (2011).","journal-title":"PLoS ONE"},{"key":"70362_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neures.2018.09.007","volume":"138","author":"N Kurabayashi","year":"2019","unstructured":"Kurabayashi, N., Nguyen, M. D. & Sanada, K. Triple play of DYRK1A kinase in cortical progenitor cells of Trisomy 21. Neurosci. Res. 138, 19\u201325. https:\/\/doi.org\/10.1016\/j.neures.2018.09.007 (2019).","journal-title":"Neurosci. Res."},{"key":"70362_CR9","doi-asserted-by":"publisher","first-page":"10268","DOI":"10.1073\/pnas.1704143114","volume":"114","author":"A Nakano-Kobayashi","year":"2017","unstructured":"Nakano-Kobayashi, A. et al. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice. Proc. Natl. Acad. Sci. USA 114, 10268\u201310273. https:\/\/doi.org\/10.1073\/pnas.1704143114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70362_CR10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/jamaneurol.2018.2210","volume":"75","author":"E Bayen","year":"2018","unstructured":"Bayen, E., Possin, K. L., Chen, Y., Cleret de Langavant, L. & Yaffe, K. Prevalence of aging, dementia, and multimorbidity in older adults with Down syndrome. JAMA Neurol. 75, 1399\u20131406. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2210 (2018).","journal-title":"JAMA Neurol."},{"key":"70362_CR11","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/ajmg.a.37674","volume":"170","author":"J Jacobs","year":"2016","unstructured":"Jacobs, J., Schwartz, A., McDougle, C. J. & Skotko, B. G. Rapid clinical deterioration in an individual with Down syndrome. Am J Med Genet A 170, 1899\u20131902. https:\/\/doi.org\/10.1002\/ajmg.a.37674 (2016).","journal-title":"Am J Med Genet A"},{"key":"70362_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.1142210","volume":"317","author":"EM Torres","year":"2007","unstructured":"Torres, E. M. et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317, 916\u2013924. https:\/\/doi.org\/10.1126\/science.1142210 (2007).","journal-title":"Science"},{"key":"70362_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-cellbio-101011-155807","volume":"28","author":"JJ Siegel","year":"2012","unstructured":"Siegel, J. J. & Amon, A. New insights into the troubles of aneuploidy. Annu. Rev. Cell Dev. Biol. 28, 189\u2013214. https:\/\/doi.org\/10.1146\/annurev-cellbio-101011-155807 (2012).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"70362_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrm4025","volume":"16","author":"S Santaguida","year":"2015","unstructured":"Santaguida, S. & Amon, A. Short- and long-term effects of chromosome mis-segregation and aneuploidy. Nat. Rev. Mol. Cell Biol. 16, 473\u2013485. https:\/\/doi.org\/10.1038\/nrm4025 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70362_CR15","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1101\/gad.269118.115","volume":"29","author":"S Santaguida","year":"2015","unstructured":"Santaguida, S., Vasile, E., White, E. & Amon, A. Aneuploidy-induced cellular stresses limit autophagic degradation. Genes Dev. 29, 2010\u20132021. https:\/\/doi.org\/10.1101\/gad.269118.115 (2015).","journal-title":"Genes Dev."},{"key":"70362_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature09529","volume":"468","author":"N Pavelka","year":"2010","unstructured":"Pavelka, N. et al. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 468, 321\u2013325. https:\/\/doi.org\/10.1038\/nature09529 (2010).","journal-title":"Nature"},{"key":"70362_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41556-018-0243-8","volume":"21","author":"NK Chunduri","year":"2019","unstructured":"Chunduri, N. K. & Storchova, Z. The diverse consequences of aneuploidy. Nat. Cell Biol. 21, 54\u201362. https:\/\/doi.org\/10.1038\/s41556-018-0243-8 (2019).","journal-title":"Nat. Cell Biol."},{"key":"70362_CR18","doi-asserted-by":"publisher","first-page":"e0219592","DOI":"10.1371\/journal.pone.0219592","volume":"14","author":"N Nawa","year":"2019","unstructured":"Nawa, N. et al. Elimination of protein aggregates prevents premature senescence in human trisomy 21 fibroblasts. PLoS ONE 14, e0219592. https:\/\/doi.org\/10.1371\/journal.pone.0219592 (2019).","journal-title":"PLoS ONE"},{"key":"70362_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cell.2010.04.037","volume":"141","author":"N Singhal","year":"2010","unstructured":"Singhal, N. et al. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 141, 943\u2013955. https:\/\/doi.org\/10.1016\/j.cell.2010.04.037 (2010).","journal-title":"Cell"},{"key":"70362_CR20","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1074\/jbc.M110.183780","volume":"286","author":"K Nishimura","year":"2011","unstructured":"Nishimura, K. et al. Development of defective and persistent Sendai virus vector: a unique gene delivery\/expression system ideal for cell reprogramming. J. Biol. Chem. 286, 4760\u20134771. https:\/\/doi.org\/10.1074\/jbc.M110.183780 (2011).","journal-title":"J. Biol. Chem."},{"key":"70362_CR21","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/nprot.2012.116","volume":"7","author":"Y Shi","year":"2012","unstructured":"Shi, Y., Kirwan, P. & Livesey, F. J. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat. Protoc. 7, 1836\u20131846. https:\/\/doi.org\/10.1038\/nprot.2012.116 (2012).","journal-title":"Nat. Protoc."},{"key":"70362_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12013-010-9138-4","volume":"60","author":"D Shen","year":"2011","unstructured":"Shen, D. et al. Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies. Cell Biochem. Biophys. 60, 173\u2013185. https:\/\/doi.org\/10.1007\/s12013-010-9138-4 (2011).","journal-title":"Cell Biochem. Biophys."},{"key":"70362_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu, W. J. et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol. Biol. Lett. 21, 29. https:\/\/doi.org\/10.1186\/s11658-016-0031-z (2016).","journal-title":"Cell Mol. Biol. Lett."},{"key":"70362_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/ars.2016.6686","volume":"26","author":"A Tramutola","year":"2017","unstructured":"Tramutola, A. et al. Polyubiquitinylation profile in Down syndrome brain before and after the development of Alzheimer neuropathology. Antioxid. Redox Signal 26, 280\u2013298. https:\/\/doi.org\/10.1089\/ars.2016.6686 (2017).","journal-title":"Antioxid. Redox Signal"},{"key":"70362_CR25","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.bbadis.2013.04.013","volume":"1832","author":"F Di Domenico","year":"2013","unstructured":"Di Domenico, F. et al. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer\u2019s disease neuropathology: redox proteomics analysis of human brain. Biochim. Biophys. Acta 1832, 1249\u20131259. https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.013 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"70362_CR26","doi-asserted-by":"publisher","first-page":"e0176307","DOI":"10.1371\/journal.pone.0176307","volume":"12","author":"S Aivazidis","year":"2017","unstructured":"Aivazidis, S. et al. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PLoS ONE 12, e0176307. https:\/\/doi.org\/10.1371\/journal.pone.0176307 (2017).","journal-title":"PLoS ONE"},{"key":"70362_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785\u2013798. https:\/\/doi.org\/10.1016\/j.neuron.2013.05.029 (2013).","journal-title":"Neuron"},{"key":"70362_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/7651_2015_251","volume":"1357","author":"SI Kim","year":"2016","unstructured":"Kim, S. I. et al. Inducible transgene expression in human iPS cells using versatile all-in-one piggyBac transposons. Methods Mol. Biol. 1357, 111\u2013131. https:\/\/doi.org\/10.1007\/7651_2015_251 (2016).","journal-title":"Methods Mol. Biol."},{"key":"70362_CR29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41598-017-00714-7","volume":"7","author":"S Omori","year":"2017","unstructured":"Omori, S. et al. A pair of maternal chromosomes derived from meiotic nondisjunction in trisomy 21 affects nuclear architecture and transcriptional regulation. Sci. Rep. 7, 764. https:\/\/doi.org\/10.1038\/s41598-017-00714-7 (2017).","journal-title":"Sci. Rep."},{"key":"70362_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0002-9440(10)64369-6","volume":"160","author":"K Zatloukal","year":"2002","unstructured":"Zatloukal, K. et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160, 255\u2013263. https:\/\/doi.org\/10.1016\/S0002-9440(10)64369-6 (2002).","journal-title":"Am. J. Pathol."},{"key":"70362_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/092986708783330692","volume":"15","author":"JA Olzmann","year":"2008","unstructured":"Olzmann, J. A., Li, L. & Chin, L. S. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr. Med. Chem. 15, 47\u201360 (2008).","journal-title":"Curr. Med. Chem."},{"issue":"Suppl","key":"70362_CR32","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl), S10-17. https:\/\/doi.org\/10.1038\/nm1066 (2004).","journal-title":"Nat. Med."},{"key":"70362_CR33","doi-asserted-by":"publisher","first-page":"e03023","DOI":"10.7554\/eLife.03023","volume":"3","author":"N Dephoure","year":"2014","unstructured":"Dephoure, N. et al. Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. Elife 3, e03023. https:\/\/doi.org\/10.7554\/eLife.03023 (2014).","journal-title":"Elife"},{"key":"70362_CR34","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1111\/j.1582-4934.2011.01374.x","volume":"15","author":"KM Doyle","year":"2011","unstructured":"Doyle, K. M. et al. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell Mol. Med. 15, 2025\u20132039. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01374.x (2011).","journal-title":"J. Cell Mol. Med."},{"key":"70362_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5607\/en.2019.28.4.504","volume":"28","author":"T Kim","year":"2019","unstructured":"Kim, T., Song, S., Park, Y., Kang, S. & Seo, H. HDAC Inhibition by valproic acid induces neuroprotection and improvement of PD-like behaviors in LRRK2 R1441G transgenic mice. Exp. Neurobiol. 28, 504\u2013515. https:\/\/doi.org\/10.5607\/en.2019.28.4.504 (2019).","journal-title":"Exp. Neurobiol."},{"key":"70362_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4103\/1673-5374.265562","volume":"15","author":"L Su","year":"2020","unstructured":"Su, L. et al. Neuroprotective mechanism of TMP269, a selective class IIA histone deacetylase inhibitor, after cerebral ischemia\/reperfusion injury. Neural Regen Res. 15, 277\u2013284. https:\/\/doi.org\/10.4103\/1673-5374.265562 (2020).","journal-title":"Neural Regen Res."},{"key":"70362_CR37","doi-asserted-by":"publisher","first-page":"93.e106","DOI":"10.1016\/j.stem.2018.10.023","volume":"24","author":"C Lang","year":"2019","unstructured":"Lang, C. et al. Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of parkinson cell phenotypes. Cell Stem Cell 24, 93.e106-106.e106. https:\/\/doi.org\/10.1016\/j.stem.2018.10.023 (2019).","journal-title":"Cell Stem Cell"},{"key":"70362_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ajmg.a.37984","volume":"173","author":"D Chung","year":"2017","unstructured":"Chung, D., Haynes, K. & Haynes, R. Surviving with trisomy 13: Provider and parent perspectives and the role of the pediatric palliative care program. Am. J. Med. Genet. A 173, 813\u2013815. https:\/\/doi.org\/10.1002\/ajmg.a.37984 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"70362_CR39","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1176\/appi.ajp.158.10.1659","volume":"158","author":"JD Pinter","year":"2001","unstructured":"Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T. & Reiss, A. L. Neuroanatomy of Down\u2019s syndrome: a high-resolution MRI study. Am J Psychiatry 158, 1659\u20131665. https:\/\/doi.org\/10.1176\/appi.ajp.158.10.1659 (2001).","journal-title":"Am J Psychiatry"},{"key":"70362_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","volume":"18","author":"S Guidi","year":"2008","unstructured":"Guidi, S. et al. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol. 18, 180\u2013197. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00113.x (2008).","journal-title":"Brain Pathol."},{"key":"70362_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.02.001","volume":"136","author":"E Dossi","year":"2018","unstructured":"Dossi, E., Vasile, F. & Rouach, N. Human astrocytes in the diseased brain. Brain Res. Bull. 136, 139\u2013156. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.02.001 (2018).","journal-title":"Brain Res. Bull."},{"key":"70362_CR42","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.15252\/embr.201540374","volume":"16","author":"N Kurabayashi","year":"2015","unstructured":"Kurabayashi, N., Nguyen, M. D. & Sanada, K. DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model. EMBO Rep. 16, 1548\u20131562. https:\/\/doi.org\/10.15252\/embr.201540374 (2015).","journal-title":"EMBO Rep."},{"key":"70362_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/emmm.201302848","volume":"6","author":"Y Hibaoui","year":"2014","unstructured":"Hibaoui, Y. et al. Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. EMBO Mol. Med. 6, 259\u2013277. https:\/\/doi.org\/10.1002\/emmm.201302848 (2014).","journal-title":"EMBO Mol. Med."},{"key":"70362_CR44","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/ncomms5430","volume":"5","author":"C Chen","year":"2014","unstructured":"Chen, C. et al. Role of astroglia in Down\u2019s syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat. Commun. 5, 4430. https:\/\/doi.org\/10.1038\/ncomms5430 (2014).","journal-title":"Nat. Commun."},{"key":"70362_CR45","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1101\/gad.207407.112","volume":"26","author":"AB Oromendia","year":"2012","unstructured":"Oromendia, A. B., Dodgson, S. E. & Amon, A. Aneuploidy causes proteotoxic stress in yeast. Genes Dev. 26, 2696\u20132708. https:\/\/doi.org\/10.1101\/gad.207407.112 (2012).","journal-title":"Genes Dev."},{"key":"70362_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cell.2010.08.038","volume":"143","author":"EM Torres","year":"2010","unstructured":"Torres, E. M. et al. Identification of aneuploidy-tolerating mutations. Cell 143, 71\u201383. https:\/\/doi.org\/10.1016\/j.cell.2010.08.038 (2010).","journal-title":"Cell"},{"key":"70362_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2018.05.003","author":"D Cox","year":"2018","unstructured":"Cox, D., Raeburn, C., Sui, X. & Hatters, D. M. Protein aggregation in cell biology: an aggregomics perspective of health and disease. Semin. Cell Dev. Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2018.05.003 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"70362_CR48","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/s0968-0004(00)89100-8","volume":"20","author":"PJ Thomas","year":"1995","unstructured":"Thomas, P. J., Qu, B. H. & Pedersen, P. L. Defective protein folding as a basis of human disease. Trends Biochem. Sci. 20, 456\u2013459. https:\/\/doi.org\/10.1016\/s0968-0004(00)89100-8 (1995).","journal-title":"Trends Biochem. Sci."},{"key":"70362_CR49","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","volume":"96","author":"E Scherzinger","year":"1999","unstructured":"Scherzinger, E. et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology. Proc. Natl. Acad. Sci. USA 96, 4604\u20134609. https:\/\/doi.org\/10.1073\/pnas.96.8.4604 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70362_CR50","doi-asserted-by":"publisher","DOI":"10.4161\/pri.28938","author":"L Cortez","year":"2014","unstructured":"Cortez, L. & Sim, V. The therapeutic potential of chemical chaperones in protein folding diseases. Prion https:\/\/doi.org\/10.4161\/pri.28938 (2014).","journal-title":"Prion"},{"key":"70362_CR51","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","volume":"101","author":"M Inden","year":"2007","unstructured":"Inden, M. et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J. Neurochem. 101, 1491\u20131504. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04440.x (2007).","journal-title":"J. Neurochem."},{"key":"70362_CR52","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.2174\/1381612811319280006","volume":"19","author":"M Cuadrado-Tejedor","year":"2013","unstructured":"Cuadrado-Tejedor, M., Ricobaraza, A. L., Torrijo, R., Franco, R. & Garcia-Osta, A. Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer s disease-like phenotype of a commonly used mouse model. Curr. Pharm. Des. 19, 5076\u20135084. https:\/\/doi.org\/10.2174\/1381612811319280006 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"70362_CR53","first-page":"1375","volume":"3","author":"A Ricobaraza","year":"2011","unstructured":"Ricobaraza, A., Cuadrado-Tejedor, M. & Garcia-Osta, A. Long-term phenylbutyrate administration prevents memory deficits in Tg2576 mice by decreasing Abeta. Front. Biosci. (Elite Ed.) 3, 1375\u20131384 (2011).","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"70362_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4161\/auto.6.2.11062","volume":"6","author":"L Qin","year":"2010","unstructured":"Qin, L., Wang, Z., Tao, L. & Wang, Y. ER stress negatively regulates AKT\/TSC\/mTOR pathway to enhance autophagy. Autophagy 6, 239\u2013247. https:\/\/doi.org\/10.4161\/auto.6.2.11062 (2010).","journal-title":"Autophagy"},{"key":"70362_CR55","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1371\/journal.pbio.0040423","volume":"4","author":"S Bernales","year":"2006","unstructured":"Bernales, S., McDonald, K. L. & Walter, P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol. 4, e423. https:\/\/doi.org\/10.1371\/journal.pbio.0040423 (2006).","journal-title":"PLoS Biol."},{"key":"70362_CR56","doi-asserted-by":"publisher","first-page":"e0223254","DOI":"10.1371\/journal.pone.0223254","volume":"14","author":"S Aivazidis","year":"2019","unstructured":"Aivazidis, S. et al. SNARE proteins rescue impaired autophagic flux in Down syndrome. PLoS ONE 14, e0223254. https:\/\/doi.org\/10.1371\/journal.pone.0223254 (2019).","journal-title":"PLoS ONE"},{"key":"70362_CR57","doi-asserted-by":"publisher","first-page":"6404035","DOI":"10.1155\/2019\/6404035","volume":"2019","author":"Y Rellmann","year":"2019","unstructured":"Rellmann, Y., Gronau, I., Hansen, U. & Dreier, R. 4-Phenylbutyric acid reduces endoplasmic reticulum stress in chondrocytes that is caused by loss of the protein disulfide isomerase ERp57. Oxid. Med. Cell Longev. 2019, 6404035. https:\/\/doi.org\/10.1155\/2019\/6404035 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"70362_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.toxlet.2017.02.023","volume":"271","author":"M Zeng","year":"2017","unstructured":"Zeng, M. et al. 4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models. Toxicol. Lett. 271, 26\u201337. https:\/\/doi.org\/10.1016\/j.toxlet.2017.02.023 (2017).","journal-title":"Toxicol. Lett."},{"key":"70362_CR59","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1073\/pnas.022631999","volume":"99","author":"HL Kang","year":"2002","unstructured":"Kang, H. L., Benzer, S. & Min, K. T. Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. USA 99, 838\u2013843. https:\/\/doi.org\/10.1073\/pnas.022631999 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70362_CR60","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1016\/j.bmcl.2013.08.001","volume":"23","author":"S Mimori","year":"2013","unstructured":"Mimori, S. et al. 4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor. Bioorg. Med. Chem. Lett. 23, 6015\u20136018. https:\/\/doi.org\/10.1016\/j.bmcl.2013.08.001 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"70362_CR61","doi-asserted-by":"publisher","first-page":"e39715","DOI":"10.1371\/journal.pone.0039715","volume":"7","author":"DS Kim","year":"2012","unstructured":"Kim, D. S. et al. Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes. PLoS ONE 7, e39715. https:\/\/doi.org\/10.1371\/journal.pone.0039715 (2012).","journal-title":"PLoS ONE"},{"key":"70362_CR62","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1073\/pnas.1616119114","volume":"114","author":"Z Zhao","year":"2017","unstructured":"Zhao, Z., Cao, L. & Reece, E. A. Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects. Proc. Natl. Acad. Sci. USA 114, 4489\u20134494. https:\/\/doi.org\/10.1073\/pnas.1616119114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70362-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70362-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70362-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:10:35Z","timestamp":1670346635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70362-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70362-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"24 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have read the journal\u2019s policy and have the following competing interests. Dr. Mahito Nakanishi is the founder and chief technology officer of Tokiwa-Bio, Inc. Ms. Manami Ohtaka is an employee of Tokiwa-Bio, Inc. The method to generate iPS cells with the SeVdp vector installing reprogramming genes is protected by the following patents: JP 4936482, JP 5633075, JP 5963309, US 9145564, US 8496941 B2, US 9365866 B2, EP 2434012, and EP 2639297. This does not alter our adherence to all the <i>Scientific Reports<\/i> policies on sharing data and materials. All other authors have no conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14047"}}